Reply to "The immunology of switching biologics in severe eosinophilic asthma patients''

被引：0
|
作者：
Eger, Katrien [1 ]
Pet, Lodewijk [1 ]
Weersink, J. M. [1 ]
Bel, Elisabeth H. [1 ]
机构：
[1] Univ Amsterdam, Amsterdam Univ Med Ctr, Dept Resp Med, F5-260 Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE | 2021年 / 9卷 / 09期
关键词：
D O I：
10.1016/j.jaip.2021.06.029
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：3529 / 3529
页数：1
相关论文
共 50 条
  • [41] The prevalence of severe asthma and severe eosinophilic asthma in Finland
    Viinanen, Arja
    Ilmarinen, Pinja
    Mehtala, Juha
    Ylisaukko-Oja, Tero
    Idanpaan-Heikkila, Juhana J.
    Kankaanranta, Hannu
    Lehtimaki, Lauri
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [42] Efficacy of Biologics on Refractory Eosinophilic Otitis Media Associated with Bronchial Asthma or Severe Uncontrolled CRSwNP
    De Corso, Eugenio
    Montuori, Claudio
    Settimi, Stefano
    Mele, Dario Antonio
    Cantiani, Alessandro
    Corbo, Marco
    Cantone, Elena
    Paludetti, Gaetano
    Galli, Jacopo
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (04)
  • [43] CLINICAL RESPONSE TO MEPOLIZUMAB IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA
    Harvey, E.
    Langton, D.
    Powell, H.
    Gibson, P.
    RESPIROLOGY, 2019, 24 : 42 - 42
  • [44] Longitudinal multi-trajectory phenotypes of severe eosinophilic asthma on type 2 biologics treatment
    Duong Duc Pham
    Lee, Ji-Hyang
    Kwon, Hyouk-Soo
    Song, Woo-Jung
    Cho, You Sook
    Kim, Hyunkyoung
    Kwon, Jae-Woo
    Park, So-Young
    Kim, Sujeong
    Hur, Gyu Young
    Kim, Byung Keun
    Nam, Young-Hee
    Yang, Min-Suk
    Kim, Mi-Yeong
    Kim, Sae-Hoon
    Lee, Byung-Jae
    Lee, Taehoon
    Park, So Young
    Kim, Min-Hye
    Cho, Young-Joo
    Park, ChanSun
    Jung, Jae-Woo
    Park, Han Ki
    Kim, Joo-Hee
    Moon, Ji-Yong
    Bhavsar, Pankaj
    Adcock, Ian M.
    Chung, Kian Fan
    Kim, Tae-Bum
    WORLD ALLERGY ORGANIZATION JOURNAL, 2024, 17 (12):
  • [45] Clinical response to mepolizumab in patients with severe eosinophilic asthma
    Harvey, Erin
    Langton, David L.
    Powell, Heather
    Gibson, Peter G.
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [46] Discontinuation of benralizumab in Canadian patients with severe eosinophilic asthma
    Noorduyn, Stephen G.
    Johnston, Karissa
    Osenenko, Kathy
    Sriskandarajah, Niroshan
    Gendron, Alain
    Mbuagbaw, Lawrence
    ERJ OPEN RESEARCH, 2021, 7 (04)
  • [47] Prevalence and impact of eosinophilic degranulation in patients with severe asthma
    Dyhre-Petersen, Nanna
    Silberbrandt, Alexander Wessely
    Von Bulow, Anna
    Mukherjee, Manali
    Porsbjerg, Celeste
    Frossing, Laurits
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [48] Mepolizumab efficacy in patients with severe eosinophilic asthma and bronchiectasis
    Crimi, Claudia
    Campisi, Raffaele
    Cacopardo, Giulia
    Doria, Giacomo
    Intravaia, Rossella
    Morena, Porto
    Sabrina, Genco
    Sorrentino, Ramona
    Crimi, Nunzio
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [49] Are biologics effective on lung hyperinflation in patients with resistant asthma? A reply
    Cazzola, Mario
    Maniscalco, Mauro
    RESPIRATORY MEDICINE, 2024, 227
  • [50] Severe asthma and biologics Data are good, listening to patients is better
    Bukstein, Don A.
    Guerra, Daniel G., Jr.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (03) : 285 - 286
12345